Genetic epidemiology of cancer: From families to heritable genes

International Journal of Cancer

Volumn 111, Issue 6, 2004, Pages 944-950

  Hemminki, Kari ^a,b   Rawal, Rajesh ^a   Chen, Bowang ^a   Bermejo, Justo Lorenzo ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer genes; Familial cancer; Familial risk; Heritability

Indexed keywords

ARTICLE; ASTROCYTOMA; CANCER EPIDEMIOLOGY; CANCER RISK; CARCINOID; CLUSTER ANALYSIS; DATA BASE; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; FAMILY; FAMILY COUNSELING; GENE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HERITABILITY; HUMAN; HYPOPHYSIS ADENOMA; INHERITANCE; KIDNEY CANCER; LUNG CANCER; PARENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; SIBLING; SQUAMOUS CELL CARCINOMA; SWEDEN; THYROID PAPILLARY CARCINOMA;

CLUSTER ANALYSIS; DATABASES, GENETIC; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; PEDIGREE; RISK ASSESSMENT; SWEDEN; WILLS;

EID: 4143133373     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20355     Document Type: Article

References (78)

1. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004;4:177-83.
2. Khoury M, Beaty T, Cohen B. Fundamentals of genetic epidemiology. Oxford: Oxford University Press, 1993.
3. Hemminki K, Shields P. Skilled use of DNA polymorphisms as a tool for polygenic cancers. Carcinogenesis 2002;23:379-80.
4. Cardon L, Bell J. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-9.
5. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-9.
6. Houlston RS, Peto J. The future of association studies of common cancers. Hum Genet 2003;112:434-5.
7. Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 2003;25:190-202.
8. Jin Q, Hemminki K, Grzybowska E, Klaes R, Soderberg M, Försti A. Integrin B3, Leu33Pro homozygosity and risk of breast cancer. J Natl Cancer Inst 2004;96:234-5.
9. Hampel H, Sweet K, Westman J, Offit K, Eng C. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 2004;41:81-91.
10. Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994;3:209-12.
11. Aitken JF, Youl P, Green A, MacLennan R, Martin NG. Accuracy of case-reported family history of melanoma in Queensland, Australia. Melanoma Res 1996;6:313-7.
12. Kerber R, Slattery M. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 1997;146:244-8.
13. Gibbs M, Stanford J, McIndoe R, Jarvik G, Kolb S, Goode E, Chakrabari L, Schuster E, Buckley V, Miller E, Brandzel S, Li S, et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999;64:776-87.
14. Glanz K, Grove J, Le Marchand L, Gotay C. Underreporting of family history of colon cancer: correlates and implications. Cancer Epidemiol Biomarkers Prev 1999;8:635-9.
15. Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H. Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 2000;36:1143-8.
16. King T, Tong L, Pack R, Spencer C, Amos C. Accuracy of family history of cancer as reported by men with prostate cancer. Urology 2002;59:546-50.
17. Carstensen B, Soll-Johanning H, Villadsen E, Söndergaard J, Lynge E. Familial aggregation of colorectal cancer in the general population. Int J Cancer 1996;68:428-35.
18. Hemminki K, Jiang Y. Familial and second gastric cancers: a nation wide epidemiologic study from Sweden. Cancer 2002;94:1157-65.
19. Hemminki K, Jiang Y. Familial and second esophageal cancers: a nation-wide epidemiologic study from Sweden. Int J Cancer 2002;98:106-9.
20. Hemminki K, Li X. Familial and second primary pancreatic cancers: a nation-wide epidemiologic study from Sweden. Int J Cancer 2003;103:525-30.
21. Hamilton S, Aaltonen L. Tumours of the digestive system: World Health Organization classification of tumours. Lyon: IARC, 2000. 314.
22. Hemminki K, Li X. Familial risk of cancer by site and histopathology. Int J Cancer 2003;103:105-9.
23. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-7.
24. Hemminki K, Czene K. Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 2002;11:1638-44.
25. Risch N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001;10:733-41.
26. Hemminki K. Genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2002;11:423.
27. Doll R, Peto R. The causes of cancer. J Natl Cancer Inst 1981;66:1191-309.
28. Parkin DM, Khlat M. Studies of cancer in migrants: rationale and methodology. Eur J Cancer 1996;32A:761-71.
29. McCredie M. Cancer epidemiology in migrant studies. Recent Results Cancer Res 1998;154:298-305.
30. Hemminki K, Li X, Czene K. Cancer risks in first generation immigrants to Sweden. Int J Cancer 2002;99:218-28.
31. Hemminki K, Li X. Cancer risks in second-generation immigrants to Sweden. Int J Cancer 2002;99:229-37.
32. Hemminki K, Li X. Cancer risk in Nordic immigrants and their offspring in Sweden. Eur J Cancer 2002;38:2428-34.
33. Hemminki K, Dong C, Vaittinen P. Cancer risks to spouses and offspring in the Family-Cancer Database. Genet Epidemiol 2001;20:247-57.
34. Hemminki K, Jiang Y. Cancer risks among long-standing spouses. Br J Cancer 2002;86:1737-40.
35. Hemminki K, Li X. Familial risks of cancer as a guide to gene identification and mode of inheritance. Int J Cancer 2004;110:291-4.
36. Hemminki K, Granström C. Familial breast cancer: scope for more susceptibility genes. Breast Cancer Res Treat 2003;82:17-22.
37. Hemminki K, Chen B. Familial risk for colorectal cancers are mainly due to heritable causes. Cancer Epidemiol Biomarkers Prev, in press.
38. Hemminki K, Dong C, Vaittinen P. Familial risks in cervix cancer: is there a hereditary component? Int J Cancer 1999;82:775-81.
39. Li X, Hemminki K. Familial and second lung cancers: a nation-wide epidemiologic study from Sweden. Lung Cancer 2003;39:255-63.
40. Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997;278:1043-50.
41. Hemminki K, Mutanen P. Genetic epidemiology of multistage carcinogenesis. Mut Res 2001;473:11-21.
42. Dong C, Hemminki K. Multiple primary cancers at colon, breast and skin (melanoma) as models for polygenic cancers. Int J Cancer 2001;92:883-7.
43. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31:33-6.
44. Lichtenstein P, Holm N, Verkasalo P, Illiado A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer. N Engl J Med 2000;343:78-85.
45. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002;99:260-6.
46. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
47. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961-72.
48. Hemminki K, Li X, Czene K. Familial risk of cancer: data for clinical counseling and cancer genetics. Int J Cancer 2004;108:109-14.
49. Petersen G, Codori A-M. Genetic testing for familial cancer. In: Vogelstein B, Kinzler K, eds. The genetic basis of human cancer, 2nd ed. New York: McGraw-Hill, 2002. 643-56.
50. German Consortium for Hereditary Breast and Ovarian Cancer. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 2002;97:472-80.
51. Vasen H, Mecklin J-P, Meera Khan P, Lynch H. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
52. Lynch H, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999;36:801-18.
53. Risch N. Searching for genetic determinants in the new millennium. Nature 2000;405:847-56.
54. Rybicki BA, Elston RC. The relationship between the sibling recurrence-risk ratio and genotype relative risk. Am J Hum Genet 2000;66:593-604.
55. Wang WYS, Cordell HJ, Todd JA. Association mapping of complex diseases in linked regions: estimation of genetic effects and feasibility of testing rare variants. Genet Epidemiol 2003;24:36-42.
56. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998;391:184-7.
57. Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002;30:406-10.
58. Hemminki K, Dong C. Familial relationships in thyroid cancer by histopathological type. Int J Cancer 2000;85:201-5.
59. Hemminki K, Li X, Collins V. A population-based study of familial central nervous system hemangioblastomas. Neuroepidemiology 2001;20:257-61.
60. Hemminki K, Li X. Familial colorectal adenocarcinoma and hereditary nonpolyposis colorectal cancer: a nation-wide epidemiological study from Sweden. Br J Cancer 2001;84:969-74.
61. Hemminki K, Zhang H, Czene K. Familial and attributable risks in cutaneous melanoma: effects of proband and age. J Invest Dermatol 2003;120:217-23.
62. Hemminki K, Granström C. Familial invasive and borderline ovarian tumors by proband status, age and histology. Int J Cancer 2003;105:701-5.
63. Hemminki K, Dong C. Familial relationships in squamous cell carcinoma of the skin. Epidemiology 2000;11:309-14.
64. Hemminki K, Li X. Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiological study from Sweden. Int J Cancer 2001;94:444-8.
65. Hemminki K, Li X, Collins V. Parental cancer as a risk factor for brain tumors (Sweden). Cancer Causes Control 2001;12:195-9.
66. Hemminki K, Jiang Y. Second primary neoplasms after 19281 endocrine gland tumours: aetilogical links? Eur J Cancer 2001;37:1886-94.
67. Plna K, Hemminki K. Re: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2001;93:323-4.
68. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Masback A, Westerdahl J, Olsson H, Ingvar C. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000;92:1260-6.
69. Terwilliger J. On the resolution and feasibility of genome scanning approaches. Adv Genet 2001;42:351-91.
70. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001;91:144-50.
71. Risch N. Linkage strategies for genetically complex traits: 1, multilocus models. Am J Hum Genet 1990;46:222-8.
72. Risch N, Merikangas K. The future of genetic studies of complex diseases. Science 1996;273:1516-7.
73. Easton D. How many more breast cancer predisposition genes are there? Breast Cancer Res 1999;1:14-7.
74. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001;17:502-10.
75. Hemminki K, Li X. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden. Gut 2003;52:592-6.
76. Hemminki K, Li X. Familial risks in nervous system tumors. Cancer Epidemiol Biomarkers Prev 2003;12:1137-42.
77. Li X, Hemminki K. Inherited predisposition to early onset lung cancer according to histological type. Int J Cancer, in press.
78. Hemminki K, Li X. Familial renal cell cancer appears to have a recessive component. J Med Genet 2004;41:E58.